MARKET RESEARCH TREND

"Acute Respiratory Distress Syndrome - Pipeline Review, H2 2016" . The Report covers current Market Trends, Analysis, Forecast, Review, Share, Size, Growth, Effect. Description- Summary Global Markets Directs, Acute Respiratory Distress Syndrome - Pipeline Review, H2 2016, provides an overview of the Acute Respiratory Distress Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Respiratory Distress Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Acute Respiratory Distress Syndrome and features dormant and discontinued projects

"Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H2, 2016" . The Report covers current Market Trends, Analysis, Forecast, Review, Share, Size, Growth, Effect. Description- Summary clinical trial report, Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H2, 2016" provides an overview of Relapsed Acute Myeloid Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on Relapsed Acute Myeloid Leukemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials databa